This study compared the effectiveness of topical 5-fluorouracil 1% (5FU) versus interferon alfa-2b eye drops as primary treatment modalities for ocular surface squamous neoplasia. Source: AAO
Bausch + Lomb’s new formulation of loteprednol etabonate ophthalmic gel, Lotemax SM 0.38%, has been cleared by the FDA for postoperative pain and inflammation. Source: AAO
This study describes the natural history of meningiomas confined to the cavernous sinus (MCSs) to better inform the choice of treatment. Source: AAO
Last week, an 80-year-old Oxford woman became the first person to receive an experimental retinal gene therapy for dry AMD. Source: AAO
Researchers report the regression patterns experienced by patients after off-label intravitreal bevacizumab therapy for retinopathy of prematurity (ROP). Source: AAO
In this study, investigators evaluated the potential association between exfoliation syndrome and chronic obstructive pulmonary disease (COPD). Source: AAO
This week, heavy smoking damages color vision and contrast sensitivity, donor corneas and ophthalmology instruments could transmit prions and the FDA has been busy approving eye-related devices and treatments. Source: AAO
This paper details the clinical characteristics of 25 patients with optic neuropathy from Behçet disease. Source: AAO
This is the largest case series assessing ocular immune-related adverse events (IRAE) in patients treated with immunotherapy agents nivolumab and ipilimumab. Source: AAO
This study evaluated the visual and refractive outcomes of small incision lenticule extraction (SMILE) for hyperopia in children. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
